Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IMT504 blocks allodynia in rats with spared nerve injury by promoting the migration of mesenchymal stem cells and by favoring an anti-inflammatory milieu at the injured nerve.
Casadei M, Fiore E, Rubione J, Domínguez LM, Coronel MF, Leiguarda C, García M, Mazzolini G, Villar MJ, Montaner A, Constandil L, Romero-Sandoval EA, Brumovsky PR. Casadei M, et al. Among authors: montaner a. Pain. 2022 Jun 1;163(6):1114-1129. doi: 10.1097/j.pain.0000000000002476. Epub 2021 Sep 15. Pain. 2022. PMID: 34711765 Free PMC article.
IMT504, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy.
Hernando Insúa A, Montaner AD, Rodriguez JM, Elías F, Fló J, López RA, Zorzopulos J, Hofer EL, Chasseing NA. Hernando Insúa A, et al. Among authors: montaner ad. Stem Cells. 2007 Apr;25(4):1047-54. doi: 10.1634/stemcells.2006-0479. Stem Cells. 2007. PMID: 17420228
PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells.
Rodriguez JM, Marchicio J, López M, Ziblat A, Elias F, Fló J, López RA, Horn D, Zorzopulos J, Montaner AD. Rodriguez JM, et al. Among authors: montaner ad. PLoS One. 2015 Feb 23;10(2):e0117484. doi: 10.1371/journal.pone.0117484. eCollection 2015. PLoS One. 2015. PMID: 25706946 Free PMC article.
Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
Bianchi MS, Bianchi S, Hernado-Insúa A, Martinez LM, Lago N, Libertun C, Chasseing NA, Montaner AD, Lux-Lantos VA. Bianchi MS, et al. Among authors: montaner ad. Am J Physiol Endocrinol Metab. 2016 Aug 1;311(2):E380-95. doi: 10.1152/ajpendo.00104.2016. Epub 2016 Jun 21. Am J Physiol Endocrinol Metab. 2016. PMID: 27329801 Free article.
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy.
Zorzopulos J, Opal SM, Hernando-Insúa A, Rodriguez JM, Elías F, Fló J, López RA, Chasseing NA, Lux-Lantos VA, Coronel MF, Franco R, Montaner AD, Horn DL. Zorzopulos J, et al. Among authors: montaner ad. World J Stem Cells. 2017 Mar 26;9(3):45-67. doi: 10.4252/wjsc.v9.i3.45. World J Stem Cells. 2017. PMID: 28396715 Free PMC article. Review.
Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization.
Leiguarda C, Villarreal A, Potilinski C, Pelissier T, Coronel MF, Bayo J, Ramos AJ, Montaner A, Villar MJ, Constandil L, Brumovsky PR. Leiguarda C, et al. Among authors: montaner a. J Neuroimmune Pharmacol. 2021 Dec;16(4):818-834. doi: 10.1007/s11481-021-09983-6. Epub 2021 Jan 27. J Neuroimmune Pharmacol. 2021. PMID: 33502706
57 results